Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Hereditary ovarian cancer. The role of BRCA1 gene dysfunction in response to chemotherapy].

Ginekologia polska - 1 Mar 2011

Blecharz Paweł, Karolewski Kazimierz, Urbański Krzysztof

Abstract excerpt

Hereditary ovarian cancer is often believed to be as a distinct disease. It is diagnosed earlier than its sporadic type; serous subtypes and more advanced stages are usually observed. Mutations of genes like BRCA1, BRCA2, MMR (MLH1, MSH2, PMS1, PMS2) are strictly associated with the heredity of ovarian and also breast cancer. Systematic controls and specific procedures to lower the risk of those tumors are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to PMS1 gene

Share to PMS2 gene

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genetic Predisposition to Disease

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 21735691

Genes

BRCA1
BRCA2
MLH1
MSH2
PMS1
PMS2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Hereditary ovarian cancer. The role of BRCA1 gene dysfunction in response to chemotherapy].PMID 21735691Read ↗

[Gynecological Care and Prevention of Gynecological Malignancies in BRCA1 and BRCA2 Mutation Carriers].Semantic proximity Read ↗

[Hereditary ovarian carcinomas: clinico-biological features and treatment].Semantic proximity Read ↗

[Hereditary forms of ovarian cancer].Semantic proximity Read ↗

'BRCAness' and its implications for platinum action in gynecologic cancer.Semantic proximity Read ↗

[Peculiarities of diagnosis, treatment and prevention of hereditary cancer of the breast and ovary. Clinical and genetic screening among BRCA1/2 mutation carriers and individuals with high family risk of cancer].Semantic proximity Read ↗

[Genetic predisposition and ovarian cancer].Semantic proximity Read ↗

[Hereditary predisposition for the development of breast and ovarian carcinoma].Semantic proximity Read ↗

[BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer].Semantic proximity Read ↗

Assessing Frequency and Clinical Outcomes of BRCA Mutated Ovarian Cancer in Saudi WomenSemantic proximity Read ↗

[Clinical-based study of ovarian cancer patients with and without BRCA1/2 genes mutation: clinical features and pedigree analysis].Semantic proximity Read ↗

[Management of hereditary ovarian cancer].Semantic proximity Read ↗

Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.